Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GSM FoilsNSE:GSMFOILS +4.97%42 Debt-to-EBITDA is 1.16 as of Mar. 2026, which is 21% below its 10-year median of 1.47. GuruFocus rates NSE:GSMFOILS with a GF Score™ of 42/100. The stock has 4 warning signs investors should review. Among 475 Medical Devices & Instruments companies, GSM Foils ranks better than 52.63% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for GSM Foils's Debt-to-EBITDA or its related term are showing as below:
NSE:GSMFOILS'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.86 Med: 1.47 Max: 2.31
Current: 1.47
During the past 6 years, the highest Debt-to-EBITDA Ratio of GSM Foils was 2.31. The lowest was 0.86. And the median was 1.47.
NSE:GSMFOILS's Debt-to-EBITDA is ranked better than 52.63% of 475
companies
in the Medical Devices & Instruments industry
Industry Median: 1.61
vs NSE:GSMFOILS: 1.47
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
GSM Foils Debt-to-EBITDA Related Terms
GSM Foils Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for GSM Foils's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:GSMFOILS vs ISRG, BDX, MDLN: Debt-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, GSM Foils's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GSM Foils Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GSM Foils's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where GSM Foils's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
GSM Foils (NSE:GSMFOILS) has a Debt-to-EBITDA of 1.16 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on GSM Foils. This is 21% below median its historical median of 1.47. Over the past decade, GSM Foils' Debt-to-EBITDA has ranged from 0.86 to 2.31. According to the industry distribution chart, GSM Foils ranks #225 out of 475 companies in the Medical Devices & Instruments industry, placing it in the top 47.4%.
Is GSM Foils' Debt-to-EBITDA too high?
GSM Foils' current Debt-to-EBITDA of 1.16 is 21% below median its 10-year median of 1.47. Over the past 10 years, this metric has ranged from a low of 0.86 to a high of 2.31. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.61. GSM Foils' value of 1.16 is 28% below this industry median. Based on the distribution chart, GSM Foils ranks #225 out of 475 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, GSM Foils has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does GSM Foils' Debt-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, GSM Foils ranks #225 out of 475 companies for Debt-to-EBITDA. This puts GSM Foils in the upper half of its industry. The industry median Debt-to-EBITDA is 1.61. GSM Foils' value of 1.16 is 28% below this benchmark. Historically, GSM Foils' own Debt-to-EBITDA has ranged from 0.86 to 2.31 over the past decade. While the company's 10-year median is 1.47 vs. the industry median of 1.61, GSM Foils has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.61, based on 475 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GSM Foils's current Debt-to-EBITDA of 1.16 is 28% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on GSM Foils. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GSM Foils's current Debt-to-EBITDA is 1.16, which is 21% below median its own 10-year median of 1.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GSM Foils stock overvalued right now?
GSM Foils (NSE:GSMFOILS) has a current Debt-to-EBITDA of 1.16. The current Debt-to-EBITDA is 1.16, which is 21% below median its 10-year median of 1.47 and 28% below the Medical Devices & Instruments industry median of 1.61. GSM Foils' overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For GSM Foils (NSE:GSMFOILS), the current Debt-to-EBITDA is 1.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GSM Foils Ltd is engaged in the business of manufacturing Blister Foils and Aluminium Pharma Foils (also known as Strip Foils) which is used in packing of pharmaceutical medicines which includes capsules and tablets both. It products includes plain and printed aluminum foils and strip foils along with alu alu base foils and it ranges from 0.020/ 0.025/ 0.030/ 0.040 micron for coated /ploy laminated/ blister/ strip printed foils. Aluminium Foil or Strip Foils are one of the packaging options for highly sensitive pharmaceutical products that protects the medicines from oxygen, moisture, and other environmental influences. Blister Foils are commonly used as unit-dose packaging for pharmaceutical tablets.
42GF Score
Get the complete analysis for NSE:GSMFOILS
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GSMFOILS has been successfully added to your 
